| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10157-009-0237-8 |
| P698 | PubMed publication ID | 19960305 |
| P2093 | author name string | Japanese Society of Nephrology | |
| P2860 | cites work | Obesity and Risk for Chronic Renal Failure | Q22241459 |
| The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents | Q22305963 | ||
| Immunosuppressive treatment for focal segmental glomerulosclerosis in adults | Q24242266 | ||
| Protein restriction for diabetic renal disease | Q24242991 | ||
| Protein restriction for children with chronic kidney disease | Q24243491 | ||
| Low protein diets for chronic kidney disease in non diabetic adults | Q24246169 | ||
| Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome | Q24246172 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group | Q28141498 | ||
| Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators | Q28144781 | ||
| The role of diastolic blood pressure when treating isolated systolic hypertension | Q28145536 | ||
| Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | Q28188162 | ||
| The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes | Q28188182 | ||
| Association between body mass index and CKD in apparently healthy men | Q28192932 | ||
| X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study | Q28205352 | ||
| J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data | Q28207840 | ||
| Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction | Q28213597 | ||
| MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q28214393 | ||
| Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) | Q28236767 | ||
| Smoking is associated with progression of diabetic nephropathy | Q28251046 | ||
| Normalization of hemoglobin level in patients with chronic kidney disease and anemia | Q28274269 | ||
| Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization | Q28283679 | ||
| A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation | Q28285964 | ||
| Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group | Q28328155 | ||
| K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 | ||
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group | Q29617736 | ||
| Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | Q29618529 | ||
| Multidisciplinary predialysis programs: quantification and limitations of their impact on patient outcomes in two Canadian settings | Q30233816 | ||
| Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study | Q45124379 | ||
| Serum phosphate levels and mortality risk among people with chronic kidney disease | Q45198981 | ||
| Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study | Q45206183 | ||
| Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study | Q45227716 | ||
| Therapeutic effects of long-term administration of an oral adsorbent in patients with chronic renal failure: two-year study | Q45231428 | ||
| Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy | Q45247211 | ||
| A double-blind, dose-response study of losartan in hypertensive children | Q45308775 | ||
| The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis | Q45344377 | ||
| Attenuated varicella virus vaccine in children with renal transplants | Q45781449 | ||
| Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up | Q46156479 | ||
| The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension | Q46169157 | ||
| Blood pressure control, drug therapy, and kidney disease | Q46213710 | ||
| Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators | Q46250134 | ||
| Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group | Q46278015 | ||
| Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients | Q46442493 | ||
| Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease | Q46460979 | ||
| Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study | Q46472704 | ||
| Influence of metabolic syndrome on hypertension-related target organ damage | Q46504497 | ||
| Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy | Q46519015 | ||
| Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus | Q46534931 | ||
| Metabolic syndrome and cardiovascular mortality in older type 2 diabetic patients: a longitudinal study | Q46535622 | ||
| Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease | Q46584977 | ||
| An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease. | Q46619074 | ||
| Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis | Q46647551 | ||
| Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension | Q46660460 | ||
| CKD progression and mortality among older patients with diabetes | Q46675363 | ||
| Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center | Q46702747 | ||
| Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease | Q46703308 | ||
| Effect of a multifactorial intervention on mortality in type 2 diabetes | Q46767642 | ||
| Effect of pravastatin in people with diabetes and chronic kidney disease | Q46776015 | ||
| The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. | Q46777787 | ||
| Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study | Q46788440 | ||
| Antiproteinuric effect of oral paricalcitol in chronic kidney disease | Q46826570 | ||
| Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study | Q46847961 | ||
| Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist | Q46867938 | ||
| Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program | Q46873807 | ||
| Body mass index and risk for end-stage renal disease | Q46876497 | ||
| Metabolic syndrome and chronic kidney disease in Okinawa, Japan | Q46891095 | ||
| Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. | Q46907551 | ||
| Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? | Q46954192 | ||
| The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population | Q46963308 | ||
| Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study | Q46987029 | ||
| A lack of increase in high molecular weight-adiponectin in macroalbuminuric subjects with metabolic syndrome may exert renal and atherosclerotic risks | Q47261117 | ||
| Impact of weight change on albuminuria in the general population | Q47297093 | ||
| Anemia in pediatric hemodialysis patients: results from the 2001 ESRD Clinical Performance Measures Project | Q47698825 | ||
| Morbidity and mortality in children with anemia at initiation of dialysis | Q47731990 | ||
| A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function | Q47957870 | ||
| Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial | Q47978262 | ||
| Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease | Q50176457 | ||
| The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. | Q50593889 | ||
| Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases | Q44235510 | ||
| Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). | Q44248797 | ||
| Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency | Q44278953 | ||
| Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials | Q44288708 | ||
| Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group | Q44289830 | ||
| Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies | Q44293250 | ||
| Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes | Q44295713 | ||
| Guidelines for the management of refractory nephrotic syndrome--from investigations between 1997 and 2001--research project team for progressive renal lesions in the Ministry of Health, Labor and Welfare, Japan | Q44329951 | ||
| Effect of nonsupplemented low-protein diet on very late stage CRF. | Q44337937 | ||
| A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. | Q44338046 | ||
| Proteinuria and the risk of developing end-stage renal disease | Q44358762 | ||
| A central body fat distribution is related to renal function impairment, even in lean subjects | Q44383378 | ||
| Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study | Q44418801 | ||
| Corticosteroids in IgA nephropathy: a randomised controlled trial | Q44419929 | ||
| Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial | Q44449839 | ||
| Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease | Q44449846 | ||
| A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children | Q44459452 | ||
| Beneficial effects of water-based exercise in patients with chronic kidney disease | Q44473773 | ||
| Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. | Q44481322 | ||
| Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study | Q44503850 | ||
| Cholesterol and the risk of renal dysfunction in apparently healthy men. | Q44521397 | ||
| Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria | Q44547732 | ||
| Acanthocyturia--a characteristic marker for glomerular bleeding | Q44563663 | ||
| Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis | Q44579295 | ||
| A population-based study of the incidence and outcomes of diagnosed chronic kidney disease | Q44603637 | ||
| Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease | Q44603644 | ||
| A double-blind, placebo-controlled, dose–response study of the effectiveness and safety of lisinopril for children with hypertension | Q44614495 | ||
| Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial | Q44705281 | ||
| Predictors of new-onset kidney disease in a community-based population | Q44717965 | ||
| The burden of chronic kidney disease in renal transplant recipients | Q44770925 | ||
| Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes | Q44804280 | ||
| Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure | Q44805620 | ||
| Randomized, double-blind, placebo-controlled trial to evaluate efficacy of ketodiet in predialytic chronic renal failure | Q44827620 | ||
| Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial | Q44901172 | ||
| Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy | Q44904214 | ||
| Obesity and the metabolic syndrome in children and adolescents | Q44919660 | ||
| Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes | Q44947020 | ||
| Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney | Q44951986 | ||
| Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial | Q44978374 | ||
| Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure | Q44978382 | ||
| Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study | Q44981445 | ||
| What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? | Q44988213 | ||
| Association between smoking and chronic renal failure in a nationwide population-based case-control study | Q45000531 | ||
| Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy | Q45012594 | ||
| Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome | Q45025843 | ||
| A randomized, placebo-controlled trial of amlodipine in children with hypertension | Q45041404 | ||
| Short-term effects of a very-low-protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients | Q45049159 | ||
| Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria | Q45113233 | ||
| Trends in blood pressure among children and adolescents | Q39281775 | ||
| Obstructive nephropathy in children: long-term progression after relief of posterior urethral valve | Q39418672 | ||
| Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group | Q39470503 | ||
| Revised equations for estimated GFR from serum creatinine in Japan | Q39513402 | ||
| Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis | Q39699397 | ||
| Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis | Q40245317 | ||
| Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study | Q40261446 | ||
| Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study | Q40347311 | ||
| Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis | Q40414255 | ||
| Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors | Q40430980 | ||
| Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. | Q40509707 | ||
| Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis | Q40539174 | ||
| A review of therapeutic studies of idiopathic membranous glomerulopathy | Q40539681 | ||
| Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors | Q40749434 | ||
| Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. | Q41050221 | ||
| Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group | Q41134203 | ||
| Long-term follow-up of kidney donors: a longitudinal study | Q41576047 | ||
| Effects of hypertension and dyslipidemia on the decline in renal function | Q41668265 | ||
| Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy | Q42164528 | ||
| Lifestyle factors, obesity and the risk of chronic kidney disease | Q42171674 | ||
| Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM. | Q42543650 | ||
| Rosuvastatin-induced arrest in progression of renal disease | Q42624458 | ||
| Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients | Q42672511 | ||
| Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. | Q43436440 | ||
| The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis | Q43490816 | ||
| Effect of lipid reduction on the progression of renal disease: a meta-analysis | Q43514434 | ||
| Effects of calcium antagonist, benidipine, on the progression of chronic renal failure in the elderly: a 1-year follow-up | Q43599147 | ||
| Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). | Q43601348 | ||
| On-treatment diastolic blood pressure and prognosis in systolic hypertension | Q43617701 | ||
| Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial | Q43626458 | ||
| The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study | Q43636269 | ||
| Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. | Q43683472 | ||
| Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. | Q43725750 | ||
| Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis | Q43730046 | ||
| Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. | Q43741361 | ||
| ABO-incompatible living-donor kidney transplantation in children | Q43752470 | ||
| Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics | Q43786660 | ||
| Evaluation of renal biopsy samples of patients with diabetic nephropathy. | Q43834425 | ||
| The prognostic significance of proteinuria: the Framingham study | Q43852381 | ||
| Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM). | Q43857789 | ||
| Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty | Q43873696 | ||
| Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy | Q43961791 | ||
| The association among smoking, heavy drinking, and chronic kidney disease | Q44029179 | ||
| Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults | Q44041092 | ||
| Expressing glomerular filtration rate in children | Q44052129 | ||
| Effect of pravastatin on proteinuria in patients with well-controlled hypertension | Q44053702 | ||
| Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect | Q44090671 | ||
| Influence of smoking and obesity on the development of proteinuria | Q44091678 | ||
| Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group | Q44134261 | ||
| 20 years or more of follow-up of living kidney donors | Q44136916 | ||
| Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy | Q44146653 | ||
| Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial | Q44218873 | ||
| Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data | Q30656350 | ||
| The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients | Q30702618 | ||
| Epidemiology of chronic renal failure in children: data from the ItalKid project | Q30782955 | ||
| Bed rest: a potentially harmful treatment needing more careful evaluation | Q30791147 | ||
| Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. | Q31046296 | ||
| Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population | Q31121930 | ||
| Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data | Q31878962 | ||
| A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. | Q33179291 | ||
| Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial | Q33181802 | ||
| Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast- induced nephropathy in chronic renal failure | Q33193610 | ||
| Meta-analysis of antiplatelet therapy for IgA nephropathy | Q33267483 | ||
| Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies | Q33337548 | ||
| A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy | Q33501981 | ||
| Optimal care of the pediatric end-stage renal disease patient on dialysis | Q33539810 | ||
| Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. | Q33738003 | ||
| Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group | Q33871976 | ||
| Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials | Q33897188 | ||
| Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration | Q33929187 | ||
| Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and eli | Q33931572 | ||
| Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes | Q33985838 | ||
| Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group | Q34025761 | ||
| Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra | Q34189543 | ||
| An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism. | Q34201444 | ||
| Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi | Q34272627 | ||
| Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy | Q34437499 | ||
| A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine | Q34461054 | ||
| Postnatal investigation of fetal renal disease | Q34464550 | ||
| Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol | Q34522261 | ||
| A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension | Q34525968 | ||
| Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials | Q34530890 | ||
| Preventing microalbuminuria in type 2 diabetes | Q34552302 | ||
| Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study | Q34720231 | ||
| Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study | Q34740928 | ||
| Severe dietary protein restriction in overt diabetic nephropathy: benefits or risks? | Q77940732 | ||
| A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity | Q78461798 | ||
| Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis | Q78571279 | ||
| Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease | Q78826992 | ||
| Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community | Q78899068 | ||
| Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study | Q79330505 | ||
| Correction of anemia with epoetin alfa in chronic kidney disease | Q79363020 | ||
| Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands | Q79394317 | ||
| Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5 | Q79475492 | ||
| Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study | Q79684893 | ||
| Association between the metabolic syndrome and chronic kidney disease in Chinese adults | Q79710703 | ||
| The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort | Q79751178 | ||
| Prevalence of complications in children with chronic kidney disease according to KDOQI | Q79761748 | ||
| Obesity is associated with family history of ESRD in incident dialysis patients | Q79782060 | ||
| Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization | Q79811373 | ||
| Blood pressure and stroke: an overview of published reviews | Q79843018 | ||
| A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study | Q79844393 | ||
| Screening, monitoring, and treatment of albuminuria: Public health perspectives | Q79851252 | ||
| Body mass index and the risk of development of end-stage renal disease in a screened cohort | Q79933214 | ||
| Protein intake of more than 0.5 g/kg BW/day is not effective in suppressing the progression of chronic renal failure | Q79976261 | ||
| Effect of early nephrology referral on the initiation of hemodialysis and survival in patients with chronic kidney disease and cardiovascular diseases | Q80033996 | ||
| Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes | Q80049813 | ||
| Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease | Q80061589 | ||
| Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--the Ohasama study | Q80065099 | ||
| Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening | Q80087723 | ||
| Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors | Q80112924 | ||
| Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study | Q80164206 | ||
| Effects of a supplemented hypoproteic diet in chronic kidney disease | Q80225271 | ||
| Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study | Q80248537 | ||
| AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases | Q80322551 | ||
| Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated | Q80341030 | ||
| IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria | Q80357706 | ||
| Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS | Q80387828 | ||
| [Guidelines for diagnosis of hematuria] | Q80472223 | ||
| Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial | Q80796980 | ||
| Association between waist-to-hip ratio and chronic kidney disease in the elderly | Q80860470 | ||
| Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure | Q80860870 | ||
| Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease | Q80977107 | ||
| The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis | Q81071489 | ||
| How old is old for transplantation? | Q81087973 | ||
| Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy | Q81312382 | ||
| The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study | Q81454959 | ||
| Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease | Q81555894 | ||
| Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy | Q81790266 | ||
| Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study | Q81847255 | ||
| Home blood pressure monitoring in CKD | Q81853685 | ||
| Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial | Q81897626 | ||
| Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease | Q82242344 | ||
| A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD | Q82971657 | ||
| Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study | Q83037849 | ||
| Stature in children with chronic kidney disease: analysis of NAPRTCS database | Q83048374 | ||
| III. Clinical practice recommendations for anemia in chronic kidney disease in children | Q83296287 | ||
| Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate | Q83853480 | ||
| Predictors of outcome in Henoch-Schönlein nephritis in children and adults | Q83861020 | ||
| Kidney transplantation without prior dialysis in children: the Eurotransplant experience | Q83984685 | ||
| Asymptomatic inferior vena cava abnormalities in three children with end-stage renal disease: risk factors and screening guidelines for pretransplant diagnosis | Q93931100 | ||
| Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure | Q74532128 | ||
| Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction | Q74587371 | ||
| Cardiovascular mortality in children and young adults with end-stage kidney disease | Q74620905 | ||
| The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide | Q74816907 | ||
| Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group | Q77223580 | ||
| Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation | Q77357987 | ||
| Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure | Q77417338 | ||
| Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program | Q77592672 | ||
| Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study | Q77647490 | ||
| A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group | Q77799068 | ||
| The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial | Q77925649 | ||
| Haematuria: glomerular or non-glomerular? | Q66704518 | ||
| Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy | Q67191592 | ||
| Long-term follow-up of childhood Henoch-Schönlein nephritis | Q67513278 | ||
| The influence of age on renal function and renin and aldosterone responses to sodium-volume expansion and contraction in normotensive and mildly hypertensive humans | Q67548508 | ||
| Prognostic Indicators in Childhood IgA Nephropathy | Q67750841 | ||
| The Natural History of Screening Detected IgA Glomerulonephritis in Children | Q67778829 | ||
| The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study | Q68033813 | ||
| Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes | Q68182150 | ||
| Comparison of ketoacids and low protein diet on advanced chronic renal failure progression | Q68221076 | ||
| Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome | Q68250648 | ||
| Meta-analysis of randomised controlled trials in patients with primary IgA nephropathy (Berger's disease) | Q68444329 | ||
| Evaluation of variability of proteinuria indices | Q68913438 | ||
| The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents | Q69035747 | ||
| Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group | Q69167761 | ||
| The effect of protein restriction on the progression of renal insufficiency | Q69256707 | ||
| Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications | Q69467422 | ||
| A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy | Q69481607 | ||
| Postnatal development of tubular phosphate reabsorption | Q70334453 | ||
| Low-protein diet supplemented by keto acids in chronic renal failure: a prospective controlled study | Q70363899 | ||
| The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group | Q70513402 | ||
| Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension | Q70558622 | ||
| Idiopathic adult focal segmental glomerulosclerosis: a clinicopathological study and response to steroid | Q70603545 | ||
| Effects of dietary protein and phosphorus restriction on the progression of early renal failure | Q70608280 | ||
| Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie | Q70680736 | ||
| The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children | Q70691570 | ||
| [Age-related changes and sex-differences in the clinical reference values--analysis of 19 tests in clinical chemistry] | Q70738988 | ||
| A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy | Q70847542 | ||
| Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients | Q70869252 | ||
| Prognosis in postural (orthostatic) proteinuria: forty to fifty-year follow-up of six patients after diagnosis by Thomas Addis | Q70884121 | ||
| Low-dose subcutaneous recombinant erythropoietin in children with chronic renal failure. Australian and New Zealand Paediatric Nephrology Association | Q70947370 | ||
| Immune response to influenza vaccination in children with renal disease | Q70947378 | ||
| Effects of caloric supplementation on growth in children with uremia | Q71075948 | ||
| Early diagnosis of juvenile renal osteodystrophy | Q71271141 | ||
| Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine | Q71329590 | ||
| Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group | Q71345195 | ||
| Early age-dependent growth impairment in chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood | Q71499763 | ||
| Renovascular disease in older patients beginning renal replacement therapy | Q71754529 | ||
| Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study | Q71777734 | ||
| Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group | Q71788675 | ||
| Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria | Q71876380 | ||
| Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment | Q72123015 | ||
| Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients | Q72133566 | ||
| Treatment of renal anemia by subcutaneous erythropoietin in children with preterminal chronic renal failure | Q72249554 | ||
| Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials | Q72252279 | ||
| Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group | Q72326262 | ||
| Treatment of hypertension in patients 80 years of age or older | Q34766135 | ||
| Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials | Q35107962 | ||
| National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification | Q35141279 | ||
| Microalbuminuria as predictor of increased mortality in elderly people | Q35167321 | ||
| Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland | Q35564197 | ||
| The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. | Q35587723 | ||
| Lupus nephritis in childhood: a review of 53 patients followed at a single center | Q35591764 | ||
| Controlled low protein diets in chronic renal insufficiency: meta-analysis | Q35820420 | ||
| Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. | Q35885198 | ||
| Effect of pravastatin on cardiovascular events in people with chronic kidney disease | Q35886206 | ||
| The Alport nephropathy: clinicopathological correlations | Q36108770 | ||
| Chronic kidney disease in children: the global perspective | Q36120049 | ||
| Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis | Q36336393 | ||
| Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review | Q36576383 | ||
| Improved renal survival in Japanese children with IgA nephropathy | Q36585452 | ||
| Effectiveness of management strategies for renal artery stenosis: a systematic review | Q36633753 | ||
| Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. | Q36666815 | ||
| Elevated body mass index and mortality risk in the elderly | Q36703092 | ||
| Glomerular filtration rate measurement and estimation in chronic kidney disease | Q36704673 | ||
| Association of oral calcitriol with improved survival in nondialyzed CKD. | Q36796771 | ||
| Cigarette smoking and incident chronic kidney disease: a systematic review | Q36836533 | ||
| Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study | Q36843397 | ||
| Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure | Q36887212 | ||
| Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure | Q36902283 | ||
| Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study | Q37054973 | ||
| Kidney disease in the elderly: update on recent literature | Q37137428 | ||
| Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial | Q37151277 | ||
| Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD | Q37221285 | ||
| Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease | Q37322636 | ||
| Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial | Q38396336 | ||
| Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial | Q38407834 | ||
| Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients | Q38467778 | ||
| Trends in levels of cholesterol in Japanese children from 1993 through 2001. | Q38478107 | ||
| The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature | Q38557081 | ||
| The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus | Q72340287 | ||
| Hypercholesterolemia--a determinant of renal function loss and deaths in IDDM patients with nephropathy | Q72365773 | ||
| Short-term effects of low protein-normal sodium diet on renal function in chronic renal failure | Q72473914 | ||
| Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial | Q72578514 | ||
| The increased risk of coronary heart disease associated with nephrotic syndrome | Q72581796 | ||
| Prospective randomised trial of early dietary protein restriction in chronic renal failure | Q72594017 | ||
| Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group | Q72742941 | ||
| Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience | Q72760765 | ||
| Cholesterol: a renal risk factor in diabetic nephropathy? | Q72809751 | ||
| European best practice guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure | Q73063678 | ||
| Exercise training and the progression of chronic renal failure | Q73069095 | ||
| Dyslipidaemia and the progression of renal disease in chronic renal failure patients | Q73100019 | ||
| Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy | Q73108248 | ||
| Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) | Q73164612 | ||
| Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group | Q73181267 | ||
| Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases | Q73215883 | ||
| Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure | Q73235842 | ||
| Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy | Q73419875 | ||
| Effect of smoking on the prevalence of albuminuria in Japanese men with non-insulin-dependent diabetes mellitus | Q73425331 | ||
| Delapril versus manidipine in hypertensive therapy to halt the type-2-diabetes-mellitus-associated nephropathy | Q73440405 | ||
| Current indications for renal biopsy: a questionnaire-based survey | Q73487060 | ||
| Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group | Q73501133 | ||
| Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE) | Q73570404 | ||
| Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors | Q73583107 | ||
| Immunization practices in children with renal disease: a report of the North American Pediatric Renal Transplant Cooperative Study | Q73594132 | ||
| Lupus nephritis in children: prognostic significance of clinicopathological findings | Q73599299 | ||
| The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group | Q73631272 | ||
| Outcome and growth of infants with severe chronic renal failure | Q73664761 | ||
| Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children | Q73726843 | ||
| Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population | Q73739060 | ||
| Early prognostic factors of infants with chronic renal failure caused by renal dysplasia | Q73806036 | ||
| Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients | Q73823702 | ||
| Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality | Q73892882 | ||
| Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study | Q73960895 | ||
| Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study | Q74048580 | ||
| Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium | Q74083409 | ||
| Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group | Q74292394 | ||
| Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994) | Q74331944 | ||
| Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy | Q74351913 | ||
| Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function | Q74352999 | ||
| Risk factors for proteinuria in a large, multiracial, southeast Asian population | Q74381393 | ||
| Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients | Q74432264 | ||
| Salt intake and renal outcome in patients with progressive renal disease | Q74469075 | ||
| Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis | Q74522001 | ||
| The metabolic syndrome and chronic kidney disease in U.S. adults | Q38941738 | ||
| Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria. | Q50625243 | ||
| Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. | Q50654391 | ||
| Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. | Q50690091 | ||
| Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial. | Q50735530 | ||
| Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. | Q50793421 | ||
| Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program. | Q50879623 | ||
| Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. | Q50888604 | ||
| Assessment of proteinuria using random urine samples. | Q50922069 | ||
| Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. | Q50934595 | ||
| Long-term effects of neonatal sodium restriction on blood pressure. | Q50963194 | ||
| IgA nephropathy: long-term prognosis for pediatric patients. | Q51049304 | ||
| Effect of an educational program on the predialysis period for patients with chronic renal failure. | Q51091857 | ||
| Excerpts from the United States Renal Data System 2007 annual data report. | Q51111289 | ||
| Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. | Q51117223 | ||
| Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003). | Q51472504 | ||
| Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. | Q51498340 | ||
| Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. | Q51555214 | ||
| Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. | Q51601011 | ||
| A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy: a 5-year report. | Q51753629 | ||
| NSAID use and progression of chronic kidney disease. | Q51762640 | ||
| Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. | Q51920926 | ||
| Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. | Q51936780 | ||
| Prognostic factors in fetal hydronephrosis: a multivariate analysis. | Q52132473 | ||
| Quantitation of proteinuria with urinary protein/creatinine ratios and random testing with dipsticks in nephrotic children. | Q52424547 | ||
| Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. | Q52539817 | ||
| Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. | Q53360030 | ||
| A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis. | Q53662998 | ||
| Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. | Q53987953 | ||
| Conservative treatment for chronic renal failure from birth: a 3-year follow-up study. | Q54068289 | ||
| Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. | Q54259944 | ||
| The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin. | Q54335703 | ||
| Clinicopathological correlation of IgA nephropathy in children. | Q54355682 | ||
| Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathy. | Q54433400 | ||
| Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART) | Q56743686 | ||
| Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial) | Q57225267 | ||
| A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy | Q57371622 | ||
| Comparative Accuracy of Renal Duplex Sonographic Parameters in the Diagnosis of Renal Artery Stenosis: Paired and Unpaired Analysis | Q57614633 | ||
| Prospective Randomized Study Evaluating the Efficacy of the Spherical Adsorptive Carbon AST-120 in Chronic Kidney Disease Patients with Moderate Decrease in Renal Function | Q57623289 | ||
| Long-Term Outcome of Renal Transplantation from Older Donors | Q57702760 | ||
| Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease | Q57772116 | ||
| No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy report from the ItalKid Project database | Q58326636 | ||
| Relationship between Metabolic Syndrome and Proteinuria in the Japanese Population | Q58366545 | ||
| Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly? | Q58855402 | ||
| Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients | Q58924654 | ||
| Long-Term Survival of Children with End-Stage Renal Disease | Q59167828 | ||
| Incidence of End-Stage Renal Disease Among Live Kidney Donors | Q59257893 | ||
| Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus | Q61855291 | ||
| Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population | Q61965156 | ||
| Preemptive kidney transplantation: the advantage and the advantaged | Q64112067 | ||
| Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie" | Q66701946 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 537-566 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Clinical and experimental nephrology | Q26842022 |
| P1476 | title | Evidence-based practice guideline for the treatment of CKD | |
| P478 | volume | 13 |
| Q36285590 | Albuminuria-reducing effect of angiotensin II receptor blocker plus hydrochlorothiazide combination therapy in renal transplant recipients |
| Q34421862 | Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients |
| Q39867989 | Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study |
| Q34831465 | Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study |
| Q51173001 | Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort. |
| Q42793406 | Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact |
| Q37804571 | Chronic kidney disease and heart failure—Bidirectional close link and common therapeutic goal |
| Q51018341 | Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan. |
| Q85623162 | Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD |
| Q40884951 | Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study |
| Q82699661 | Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension |
| Q53061814 | Comparison of diameter-axial-polar nephrometry and RENAL nephrometry score for treatment decision-making in patients with small renal mass. |
| Q47237360 | Decreased physical function in pre-dialysis patients with chronic kidney disease |
| Q31090550 | Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method. |
| Q89324590 | Effect of carperitide on in-hospital mortality of patients admitted for heart failure: propensity score analyses |
| Q54651889 | Effects of atorvastatin and ezetimibe on endothelial function in dyslipidemic patients with chronic kidney disease. |
| Q26853636 | Endoscopic submucosal dissection in early gastric cancer in elderly patients and comorbid conditions |
| Q36090689 | GFR at initiation of dialysis and mortality in CKD: a meta-analysis |
| Q34539337 | High serum bicarbonate level within the normal range prevents the progression of chronic kidney disease in elderly chronic kidney disease patients |
| Q64990162 | Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study. |
| Q86592825 | Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study |
| Q37455310 | Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects. |
| Q58800695 | Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation |
| Q49232902 | Management of Osteoporosis in Chronic Kidney Disease |
| Q44707707 | Medication-prescribing patterns of primary care physicians in chronic kidney disease. |
| Q50981192 | Moderate-intensity single exercise session does not induce renal damage. |
| Q35303218 | Moderately increased albuminuria is an independent risk factor of cardiovascular events in the general Japanese population under 75 years of age: the Watari study |
| Q36192077 | Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairment |
| Q92544364 | Preoperative Comorbidities and Outcomes of Medically Complex Living Kidney Donors |
| Q64091956 | Previously-initiated hemodialysis as prognostic factor for in-hospital mortality in pneumonia patients with stage 5 chronic kidney disease: Retrospective database study of Japanese hospitals |
| Q51243351 | Profiles of vitamin D insufficiency and deficiency in Japanese men and women: association with biological, environmental, and nutritional factors and coexisting disorders: the ROAD study. |
| Q86726990 | Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study |
| Q92885494 | Rapid weight loss with dietary salt restriction in hospitalized patients with chronic kidney disease |
| Q34508691 | Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography |
| Q89895373 | Relationship between Serum Vitamin D and Leg Strength in Older Adults with Pre-Dialysis Chronic Kidney Disease: A Preliminary Study |
| Q85028966 | Relationship between dietary intake and microalbuminuria: findings from the Takahata study |
| Q82732442 | Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patients |
| Q33721299 | Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar |
| Q36158877 | Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria |
| Q35579521 | Renal dysfunction is an independent risk factor for bleeding after gastric ESD |
| Q37861571 | Role of chronic kidney disease in cardiovascular disease: are we different from others? |
| Q33628211 | Serum adiponectin levels predict the risk of coronary heart disease in Japanese patients with type 2 diabetes |
| Q33983591 | Significance of past history of renal failure for the detection of high-risk individuals for cardiovascular and end-stage renal disease: analysis of data from a nationwide health checkup |
| Q34317722 | Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease |
| Q83172515 | The association between renal tubular damage and rapid renal deterioration in the Japanese population: the Takahata study |
| Q35007909 | The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level |
| Q36586863 | Time-dependent risk factors associated with the decline of estimated GFR in CKD patients |
| Q51533289 | Validation of the equations for estimating daily sodium excretion from spot urine in patients with chronic kidney disease. |
Search more.